Lauren E. Colbert, MD, MSCR
Department of Rad Onc Dept., Division of Radiation Oncology
About Dr. Lauren E. Colbert
Dr. Colbert is a Radiation Oncologist who specializes in the treatment of gynecologic cancers, including cervical, endometrial and ovarian cancers, and also in the palliative treatment of other cancers that have spread to the bone in our Rapid Access Bone Metastasis Clinic. Similarly, her clinical research focuses on both new approaches to treatment of cervical cancers and clinical workflows that can improve patients’ experiences with palliative radiation and decrease resource utilization, so needed radiotherapy can be delivered in low resource settings. She also has a translational research laboratory that focuses on understanding why and how human papillomavirus (HPV) related cancers (such as cervical, anal and oropharyngeal cancers) respond to radiation. The goal of this research is to improve survival and decrease side effects from these cancers through finding markers in the tumor or blood.
Present Title & Affiliation
Primary Appointment
Full Faculty Member, Department of Cancer Biology, Division of Radiation Oncology, MD Anderson/UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX
Clinical Assistant Professor, Department of Radiation Oncology, University of Texas Medical Branch (UTMB) Health, Galveston, TX
Assistant Professor, Department of Radiation Oncology, The University of Texas (UT) MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Full Faculty Member, Department of Cancer Biology, MD Anderson/UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX
Clinical Assistant Professor, Department of Radiation Oncology, University of Texas Medical Branch (UTMB) Health, Galveston, TX
Assistant Professor, Department of Radiation Oncology, The University of Texas (UT) MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2014 | Emory University Laney Graduate School, Atlanta, Georgia, US, Master of Science in Clinical Research, MSCR |
| 2014 | Emory University School of Medicine, Atlanta, Georgia, US, MD |
| 2009 | Hope College, Holland, Michigan, US, Chemistry, Religion (dual major), BA |
Postgraduate Training
| 2015-2019 | Clinical Residency, Radiation Oncology, UT MD Anderson Cancer Center, Houston, Texas |
| 2014-2015 | Clinical Residency, Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York |
Board Certifications
| 2020 | American Board of Radiology |
Experience & Service
Administrative Appointments/Responsibilities
Co-Director, Brachytherapy Clinical Operations, Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX, 2024 - Present
Director of Innovation in Interventional Radiation Oncology, Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX, 2024 - Present
Co-Director, Platform for Innovative Microbiome and Translational Research (PRIME-TR), UT MD Anderson Cancer Center, Houston, TX, 2024 - Present
Education Director (Department level), Department of Gynecologic Section, Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX, 2019 - 2024
Other Appointments/Responsibilities
Founder and Lead, Rapid Access Bone Metastasis Clinic, UT MD Anderson Cancer Center, Houston, TX, 2015 - 2024
Institutional Committee Activities
Member, Institutional Review Board, 2022 - 2024
Member, Academic Review Committee for the Division of Education & Training, 2020 - 2024
Member, Grand Rounds and Planning Clinic Curriculum Planning Committee, 2020 - Present
Member, ROSI Advanced Imaging Scientific Review Committee, 2020 - 2021
Member, Radiation Oncology Clinical Competency Committee, 2019 - 2024
Member, Radiation Oncology Residency Program Interview Committee, 2018 - 2022
Honors & Awards
| 2025 | The Cullen M. Taniguchi Brilliant Star Award, The University of Texas MD Anderson Cancer Center |
| 2024 | Andrew Sabin Family Fellows Award, UT MD Anderson Cancer Center (Andrew Sabin Family Fellows Program) |
| 2024 | Cullen M. Taniguchi Excellence in Research Award, UT MD Anderson Cancer Center |
| 2024 | Excellence in Science, MD Anderson Cancer Center |
| 2024 | Faculty Scholar Award, MD Anderson Cancer Center |
| 2019 | Thomas H. and Mayme P. Scott Endowed Fellowship in Cancer Research, UT MD Anderson Cancer Center |
| 2018 | 1st Place Clinical Abstract, Trainee Research Day, UT MD Anderson Cancer Center |
| 2018 | AACR/ASCO Methods in Clinical Cancer Research Workshop |
| 2018 | ASTRO Travel Award, ASTRO Annual Meeting |
| 2018 | Best of ASTRO Award, ASTRO Annual Meeting |
| 2018 | Conquer Cancer Foundation Merit Award, American Society of Clinical Oncology (ASCO) |
| 2018 | Dr. Mary Fletcher Memorial Award for the Heart of Caring, UT MD Anderson Cancer Center |
| 2018 | Gilbert Fletcher Award for Most Outstanding Presentation, UT MD Anderson Cancer Center (Gilbert Fletcher Society Residents/Fellow Research Forum) |
| 2018 | Jesse H. Jones Endowed Fellowship in Cancer Education, UT MD Anderson Cancer Center |
| 2018 | Resident/Fellow Institutional Excellence Award for Teaching, UT MD Anderson Cancer Center |
| 2013 - 2014 | Joseph B. Whitehead Foundation Scholarship for Academic Merit, Emory University School of Medicine |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Seo A, Xiao W, Gjyshi O, Yoshida-Court K, Wei P, Swanson D, Cisneros Napravnik T, Grippin A, Venkatesan AM, Jacobsen MC, Fuentes DT, Lynn E, Sammouri J, Jhingran A, Joyner M, Lin LL, Colbert LE, Gillison ML, Klopp AH. Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation. Clin Cancer Res 31(4):697-706, 2024. e-Pub 2024. PMID: 39680029.
- Schrank BR, Colbert LE. Genomic biomarkers predict response to combined ATR inhibition and radiotherapy. Clin Cancer Res 30(24):5505-5507, 2024. e-Pub 2024. PMID: 39422899.
- Wang R, Harris T, Negron-Figueroa D, Lo D, Judge A, Walters D, Jiang B, Colbert LE. Protocol for culturing patient-derived organoids of cervical cancer. STAR Protoc 5(4):103353, 2024. e-Pub 2024. PMID: 39356641.
- Negron-Figueroa D, Colbert LE. Mechanisms by Which the Intratumoral Microbiome May Potentiate Immunotherapy Response. J Clin Oncol 42(28):3350-3352, 2024. e-Pub 2024. PMID: 39058969.
- Andring, L, Corrigan, KL, Reeve, BB, Meyer, LA, Wang, XS, Smith, GL, Bailard, NS, Domingo, M, Fellman, B, Varkey, J, Foster-Mills, T, Lin, L, Jhingran, A, Colbert, LE, Eifel, PJ, Klopp, AH, Joyner, MM. The Value of Patient-Reported Outcomes to Predict Symptom Burden and Health-Related Quality of Life After Chemoradiation for Cervical Cancer. Practical radiation oncology 14(5):e353-e361, 2024. e-Pub 2024. PMID: 38825227.
- Garcia, NA, Viveros-Carreño, D, Melamed, A, Pareja, R, Kanbergs, A, Wu, C, Wilke, RN, Colbert, LE, Rauh-Hain, JA. Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer. International Journal of Gynecological Cancer 34(8):1149-1155, 2024. e-Pub 2024. PMID: 38925662.
- Karpinets TV, Mitani Y, Chang CC, Wu X, Song X, Flores II, McDaniel LK, Hoballah YM, Veguilla FJ, Ferrarotto R, Colbert LE, Ajami NJ, Jenq RR, Zhang J, Futreal AP, El-Naggar AK. Intratumoral microbiome of adenoid cystic carcinomas and comparison with other head and neck cancers. Sci Rep 14(1):16300, 2024. e-Pub 2024. PMID: 39009605.
- Kim M, Maldonado JA, Pandey P, El Alam MB, Kouzy R, Christopherson K, Minsky BD, Nugyen QN, Grosshans D, Lin LL, Mitchell MP, Klopp AH, Lee PP, Bird J, Satcher R, Lewis VO, Lin PP, Tang C, Koong AC, Moon B, Colbert LE. Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic. BMJ Support Palliat Care 14(e2), 2024. e-Pub 2024. PMID: 38843933.
- Sammouri J, Venkatesan AM, Lin LL, Jhingran A, Klopp AH, Joyner MM, Eifel PJ, Colbert LE. Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement. Gynecol Oncol 180:24-34, 2024. e-Pub 2024. PMID: 38041900.
- Yoder AK, Lakomy DS, Wu J, Andring LM, Corrigan KL, Fellman B, Jhingran A, Klopp AH, Colbert LE, Soliman PT, Frumovitz MM, Peterson SK, Lin LL. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy 23(1):1-9, 2024. e-Pub 2024. PMID: 37914588.
- Manzar GS, Alam MBE, Lynn EJ, Karpinets TV, Harris T, Lo D, Yoshida-Court K, Napravnik TC, Sammouri J, Lin D, Andring LM, Bronk J, Wu X, Sims TT, Mathew G, Schmeler KM, Eifel PJ, Jhingran A, Lin LL, Joyner MM, Zhang J, Futreal A, Klopp AH, Colbert LE. Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy. Brachytherapy 23(2):123-135, 2024. e-Pub 2024. PMID: 38129211.
- Taniguchi CM, Frakes JM, Aguilera TA, Palta M, Czito B, Bhutani MS, Colbert LE, Abi Jaoude J, Bernard V, Pant S, Tzeng CD, Kim DW, Malafa M, Costello J, Mathew G, Rebueno N, Koay EJ, Das P, Ludmir EB, Katz MHG, Wolff RA, Beddar S, Sawakuchi GO, Moningi S, Slack Tidwell RS, Yuan Y, Thall PF, Beardsley RA, Holmlund J, Herman JM, Hoffe SE. Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. Lancet Oncol 24(12):1387-1398, 2023. e-Pub 2023. PMID: 38039992.
- Andring LM, Corrigan KL, Rooney M, Bailard N, Domingo M, Fellman B, Varkey J, Foster-Mills T, Kazantsev T, Lin L, Jhingran A, Colbert L, Eifel P, Klopp AH, Joyner M. Patient reported outcomes for women undergoing definitive chemoradiation for gynecologic cancer: A prospective clinical trial. Pract Radiat Oncol 13(6):e538-e546, 2023. e-Pub 2023. PMID: 37597615.
- Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, Harris TA, Elnaggar JH, Yoshida-Court K, Tomasic K, Bronk JK, Sammouri J, Yanamandra AV, Olvera AV, Carlin LG, Sims T, Delgado Medrano AY, Napravnik TC, O'Hara M, Lin D, Abana CO, Li HX, Eifel PJ, Jhingran A, Joyner M, Lin L, Ramondetta LM, Futreal AM, Schmeler KM, Mathew G, Dorta-Estremera S, Zhang J, Wu X, Ajami NJ, Wong M, Taniguchi C, Petrosino JF, Sastry KJ, Okhuysen PC, Martinez SA, Tan L, Mahmud I, Lorenzi PL, Wargo JA, Klopp AH. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell 41(11):1945-1962.e11, 2023. e-Pub 2023. PMID: 37863066.
- Sammouri J, Wong MC, Lynn EJ, El Alam MB, Lo DK, Lin D, Harris TH, Karpinets TV, Court K, Napravnik TC, Wu X, Zhang J, Klopp AH, Ajami NJ, Colbert LE. Serial genotyping of the human papillomavirus in cervical cancer: an insight into virome dynamics during chemoradiation therapy. Int J Radiat Oncol Biol Phys 116(5):1043-1054, 2023. e-Pub 2023. PMID: 36801350.
- Teka B, Yoshida-Court K, Firdawoke E, Chanyalew Z, Gizaw M, Addissie A, Mihret A, Colbert LE, Napravnik TC, El Alam MB, Lynn EJ, Mezzari M, Anuja J, Kantelhardt EJ, Kaufmann AM, Klopp AH, Abebe T. Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian Women. Microorganisms 11(4), 2023. e-Pub 2023. PMID: 37110255.
- Gjyshi O, Grippin A, Andring L, Jhingran A, Lin LL, Bronk J, Eifel PJ, Joyner MM, Sastry JK, Yoshida-Court K, Solley TN, Napravnik TC, O'Hara MP, Hegde VL, Colbert LE, Klopp AH. Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer. Clin Transl Radiat Oncol 39(100578):100578, 2023. e-Pub 2023. PMID: 36935860.
- Yoder AK, Lakomy DS, Wu J, Andring LM, Fellman B, Colbert LE, Jhingran A, Klopp AH, Soliman P, Peterson SK, Lin LL. Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors. Clin Oncol (R Coll Radiol) 35(2):e215-e226, 2023. e-Pub 2023. PMID: 36494250.
- Yoshida-Court K, Karpinets TV, Mitra A, Solley TN, Dorta-Estremera S, Sims TT, Delgado Medrano AY, El Alam MB, Ahmed-Kaddar M, Lynn EJ, Sastry KJ, Zhang J, Futreal A, Nick A, Lu K, Colbert LE, Klopp AH. Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer. PLoS One 18(1):e0279590, 2023. e-Pub 2023. PMID: 36607962.
- Elnaggar JH, Huynh VO, Lin D, Hillman RT, Abana CO, El Alam MB, Tomasic KC, Karpinets TV, Kouzy R, Phan JL, Wargo J, Holliday EB, Das P, Mezzari MP, Ajami NJ, Lynn EJ, Minsky BD, Morris VK, Milbourne A, Messick CA, Klopp AH, Futreal PA, Taniguchi CM, Schmeler KM, Colbert LE. HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development. Front Immunol 14:1051431, 2023. e-Pub 2023. PMID: 37063829.
- Netherton TJ, Nguyen C, Cardenas CE, Chung C, Klopp AH, Colbert LE, Rhee DJ, Peterson CB, Howell R, Balter P, Court LE. An automated treatment planning framework for spinal radiotherapy and vertebral level second check. Int J Radiat Oncol Biol Phys 114(3):516-528, 2022. e-Pub 2022. PMID: 35787928.
- Karpinets TV, Wu X, Solley T, El Alam MB, Sims TT, Yoshida-Court K, Lynn E, Ahmed-Kaddar M, Biegert G, Yue J, Song X, Sun H, Petrosino JF, Mezzari MP, Okhuysen P, Eifel PJ, Jhingran A, Lin LL, Schmeler KM, Ramondetta L, Ajami N, Jenq RR, Futreal A, Zhang J, Klopp AH, Colbert LE. Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure. BMC Cancer 22(1):945, 2022. e-Pub 2022. PMID: 36050658.
- Lin D, El Alam MB, Jaoude JA, Kouzy R, Phan JL, Elnaggar JH, Resendiz B, Medrano AYD, Lynn EJ, Nguyen ND, Noticewala SS, Mathew GG, Holliday EB, Minsky BD, Das P, Morris VK, Eng C, Mezzari MP, Petrosino JF, Ajami NJ, Klopp AH, Taniguchi CM, Colbert LE. Microbiome Dynamics During Chemoradiation Therapy for Anal Cancer. Int J Radiat Oncol Biol Phys 113(5):974-984, 2022. e-Pub 2022. PMID: 35513187.
- Corrigan KL, Yoder A, De B, Lin L, Jhingran A, Joyner MM, Eifel PJ, Colbert LE, Lu KH, Klopp AH. Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis. Gynecol Oncol 164(3):550-557, 2022. e-Pub 2022. PMID: 34974906.
- Colbert LE, El MB, Lynn EJ, Bronk J, Karpinets TV, Wu X, Chapman BV, Sims TT, Lin D, Kouzy R, Sammouri J, Biegert G, Delgado Medrano AY, Olvera A, Sastry KJ, Eifel PJ, Jhingran A, Lin L, Ramondetta LM, Futreal AP, Jazaeri AA, Schmeler KM, Yue J, Mitra A, Yoshida-Court K, Wargo JA, Solley TN, Hegde V, Nookala SS, Yanamandra AV, Dorta-Estremera S, Mathew G, Kavukuntla R, Papso C, Ahmed-Kaddar M, Kim M, Zhang J, Reuben A, Holliday EB, Minsky BD, Koong AC, Koay EJ, Das P, Taniguchi CM, Klopp A. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers. Cancer Immunol Res 10(2):259-271, 2022. e-Pub 2022. PMID: 35045973.
- Bronk JK, Kapadia C, Wu X, Chapman BV, Wang R, Karpinets TV, Song X, Futreal AM, Zhang J, Klopp AH, Colbert LE. Feasibility of a novel non-invasive swab technique for serial whole-exome sequencing of cervical tumors during chemoradiation therapy. PLoS One 17(10):e0274457, 2022. e-Pub 2022. PMID: 36201462.
- Wu J, Lakomy DS, Fellman BM, Salcedo MP, Sood AK, Jhingran A, Klopp AH, Iyer RB, Jimenez C, Colbert LE, Eifel PJ, Schmeler KM, Lin LL. Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment. Pract Radiat Oncol 12(5):e423-e433, 2022. e-Pub 2022. PMID: 35390531.
- Spiotto MT, Taniguchi CM, Klopp AH, Colbert LE, Lin SH, Wang L, Frederick MJ, Osman AA, Pickering CR, Frank SJ. Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies. Semin Radiat Oncol 31(4):274-285, 2021. e-Pub 2021. PMID: 34455983.
- Biegert G, El Alam MB, Karpinets T, Wu X, Sims TT, Yoshida-Court K, Lynn EJ, Yue J, Medrano AD, Petrosino J, Mezzari MP, Ajami NJ, Solley T, Ahmed-Kaddar M, Klopp AH, Colbert LE. Diversity and composition of gut microbiome of cervical cancer patients: Do results of 16S rRNA sequencing and whole genome sequencing approaches align?. J Microbiol Methods 185:106213, 2021. e-Pub 2021. PMID: 33785357.
- Sims TT, Colbert LE, Klopp AH. The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer. J Immunother Precis Oncol 4(2):72-78, 2021. e-Pub 2021. PMID: 35663536.
- Grant SR, Smith BD, Colbert LE, Nguyen QN, Yu JB, Lin SH, Chen AB. National Quality Measure Compliance for Palliative Bone Radiation Among Patients With Metastatic Non-Small Cell Lung Cancer. J Natl Compr Canc Netw 19(13):1-6, 2021. e-Pub 2021. PMID: 34044365.
- Sims TT, El Alam MB, Karpinets TV, Dorta-Estremera S, Hegde VL, Nookala S, Yoshida-Court K, Wu X, Biegert GWG, Delgado Medrano AY, Solley T, Ahmed-Kaddar M, Chapman BV, Sastry KJ, Mezzari MP, Petrosino JF, Lin LL, Ramondetta L, Jhingran A, Schmeler KM, Ajami NJ, Wargo J, Colbert LE, Klopp AH. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Commun Biol 4(1):237, 2021. e-Pub 2021. PMID: 33619320.
- Grant SR, Smith BD, Pandey P, Maldonado JA, Kim M, Moon BS, Colbert LE. Does a Custom Electronic Health Record Alert System Improve Physician Compliance With National Quality Measures for Palliative Bone Metastasis Radiotherapy?. JCO Clin Cancer Inform 5:36-44, 2021. e-Pub 2021. PMID: 33411621.
- Bahig H, Fuller CD, Mitra A, Yoshida-Court K, Solley T, Ping Ng S, Abu-Gheida I, Elgohari B, Delgado A, Rosenthal DI, Garden AS, Frank SJ, Reddy JP, Colbert L, Klopp A. Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer. Clin Transl Radiat Oncol 26:98-103, 2021. e-Pub 2021. PMID: 33367119.
- El Alam MB, Sims TT, Kouzy R, Biegert GWG, JABI J, Karpinets TV, Yoshida-Court K, Wu X, Delgado-Medrano AY, Mezzari MP, Ajami NJ, Solley T, Ahmed-Kaddar M, Lin LL, Ramondetta L, Jazaeri A, Jhingran A, Eifel PJ, Schmeler KM, Wargo J, Klopp AH, Colbert LE. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers. PLoS One 16(3):e0247905, 2021. e-Pub 2021. PMID: 33662003.
- Kouzy R, Abi Jaoude J, Lin D, El Alam MB, Minsky BD, Koay EJ, Das P, Holliday EB, Klopp AH, Colbert LE, Taniguchi CM. Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern Chemoradiation. JCO Oncol Pract 16(12):OP2000122, 2020. e-Pub 2020. PMID: 32609585.
- Karpinets TV, Solley TN, Mikkelson MD, Dorta-Estremera S, Nookala SS, Medrano AYD, Petrosino JF, Mezzari MP, Zhang J, Futreal PA, Sastry KJ, Colbert LE, Klopp A. Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice. Cancer Prev Res (Phila) 13(12):997-1006, 2020. e-Pub 2020. PMID: 32917644.
- Sims TT, Biegert GWG, Ramogola-Masire D, Ngoni K, Solley T, Ning MS, El Alam MB, Mezzari M, Petrosino J, Zetola NM, Schmeler KM, Colbert LE, Klopp AH, Grover S. Tumor Microbial Diversity and Compositional Differences Among Women in Botswana with High-Grade Cervical Dysplasia and Cervical Cancer. Int J Gynecol Cancer 30(8):1151-1156, 2020. e-Pub 2020. PMID: 32675252.
- Lin D, Kouzy R, Abi Jaoude J, Noticewala SS, Delgado Medrano AY, Klopp AH, Taniguchi CM, Colbert LE. Microbiome factors in HPV-driven carcinogenesis and cancers. PLoS Pathog 16(6):e1008524, 2020. e-Pub 2020. PMID: 32497113.
- Mitra A, Grossman Biegert GW, Delgado AY, Karpinets TV, Solley TN, Mezzari MP, Yoshida-Court K, Petrosino JF, Mikkelson MD, Lin L, Eifel P, Zhang J, Ramondetta LM, Jhingran A, Sims TT, Schmeler K, Okhuysen P, Colbert LE, Klopp AH. Microbial Diversity and Composition is Associated with Patient-Reported Toxicity during Chemo radiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys 107(1):163-171, 2020. e-Pub 2020. PMID: 31987960.
- Epstein AS, Yang A, Colbert LE, Voigt LP, Meadows J, Goldberg JI, Saltz LB. Outcomes of ICU Admission of Patients With Progressive Metastatic Gastrointestinal Cancer. J Intensive Care Med 35(3):885066617748874, 2020. e-Pub 2020. PMID: 29262748.
- Kahn J, Goodman CR, Albert A, Agarwal A, Jeans E, Tye K, Campbell SR, Marcrom S, Colbert LE. Top Concerns of Radiation Oncology Trainees in 2019: Job Market, Board Examinations, and Residency Expansion. Int J Radiat Oncol Biol Phys 106(1):19-25, 2020. e-Pub 2020. PMID: 31648872.
- Slagowski JM, Colbert LE, Cazacu IM, Singh BS, Martin R, Koay EJ, Taniguchi CM, Koong AC, Bhutani MS, Herman JM, Beddar S. Evaluation of the Visibility and Artifacts of 11 Common Fiducial Markers for Image-Guided Stereotactic Body Radiation Therapy in the Abdomen. Pract Radiat Oncol 10(6):434-442, 2020. e-Pub 2020. PMID: 31988039.
- Colbert LE, Jhingran A. Immunotherapy and Radiation. Adv Exp Med Biol 1244:205-213, 2020. e-Pub 2020. PMID: 32301016.
- Sims TT, Colbert LE, Zheng J, Delgado Medrano AY, Hoffman KL, Ramondetta L, Jazaeri A, Jhingran A, Schmeler KM, Daniel CR, Klopp A. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls. Gynecol Oncol 155(2):237-244, 2019. e-Pub 2019. PMID: 31500892.
- Osborn VW, Doke K, Griffith KA, Jones R, Lee A, Maquilan G, Masters AH, Albert AA, Dover LL, Puckett LL, Hentz C, Kahn JM, Colbert LE, Barry PN, Jagsi R. A Survey Study of Female Radiation Oncology Residents' Experiences to Inform Change. Int J Radiat Oncol Biol Phys 104(5):999-1008, 2019. e-Pub 2019. PMID: 31108141.
- Fujimoto TN, Colbert LE, Huang Y, Molkentine JM, Deorukhkar A, Baseler L, Cruz Bonilla DL, Yu M, Lin D, Gupta S, Cabeceiras PK, Kingsley CV, Tailor RC, Sawakuchi GO, Koay EJ, Piwnica-Worms H, Maitra A, Co-first authorship TC. Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Cancer Res 79(9):2327-2338, 2019. e-Pub 2019. PMID: 31043430.
- Marcrom SR, Kahn JM, Colbert LE, Freese CM, Doke KN, Yang JC, Yashar CM, Luu M, Kamrava M. Brachytherapy Training Survey of Radiation Oncology Residents. Int J Radiat Oncol Biol Phys 103(3):557-560, 2019. e-Pub 2019. PMID: 30612963.
- Dorta-Estremera S, Colbert LE, Nookala SS, Yanamandra AV, Yang G, Delgado A, Mikkelson M, Eifel P, Jhingran A, Lilie LL, Welsh J, Schmeler K, Sastry JK, Klopp A. Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer. Int J Radiat Oncol Biol Phys 102(3):593-600, 2018. e-Pub 2018. PMID: 30017792.
- Colbert LE, Rebueno N, Moningi S, Beddar S, Sawakuchi GO, Herman JM, Koong AC, Das P, Holliday EB, Koay EJ, Taniguchi CM. Dose escalation for locally advanced pancreatic cancer: How high can we go?. Adv Radiat Oncol 3(4):693-700, 2018. e-Pub 2018. PMID: 30370371.
- Dharmarajan KV, Rich SE, Johnstone CA, Hertan LM, Wei R, Colbert LE, Jones JA, Kamal AH, Jones CA. Top 10 Tips Palliative Care Clinicians Should Know About Radiation Oncology. J Palliat Med 21(3):383-388, 2018. e-Pub 2018. PMID: 29431573.
- Desai AV, Epstein AS, Colbert LE, Saltz LB. Author's Response. J Pain Symptom Manage 55(1):e2-e3, 2018. e-Pub 2018. PMID: 29146195.
- Desai AV, Epstein AS, Colbert LE, Saltz LB. Discharge to Subacute Rehabilitation Facilities Does Not Benefit Patients Hospitalized With Progressive Gastrointestinal Cancer. J Pain Symptom Manage 54(2):e4-e7, 2017. e-Pub 2017. PMID: 28438586.
- Colbert LE, Moningi S, Chadha A, Amer A, Lee Y, Wolff RA, Varadhachary G, Fleming J, Katz M, Das P, Krishnan S, Koay EJ, Park P, Crane CH, Taniguchi CM. Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC. Adv Radiat Oncol 2(3):403-415, 2017. e-Pub 2017. PMID: 29114609.
- Wei RL, Colbert LE, Jones J, Racsa M, Kane G, Lutz S, Vapiwala N, Dharmarajan KV. Palliative care and palliative radiation therapy education in radiation oncology: A survey of US radiation oncology program directors. Pract Radiat Oncol 7(4):234-240, 2017. e-Pub 2017. PMID: 28222994.
- Colbert LE, Cloyd JM, Koay EJ, Crane CH, Vauthey JN. Proton beam radiation as salvage therapy for bilateral colorectal liver metastases not amenable to second-stage hepatectomy. Surgery 161(6):1543-1548, 2017. e-Pub 2017. PMID: 28081954.
- Tanenbaum DG, Hall WA, Colbert LE, Bastien AJ, Brat DJ, Kong J, Kim S, Dwivedi B, Kowalski J, Landry JC, Yu DS. TNFRSF10C copy number variation is associated with metastatic colorectal cancer. J Gastrointest Oncol 7(3):306-14, 2016. e-Pub 2016. PMID: 27284460.
- Tanenbaum DG, Hall WA, Mittal P, Nickleach DC, Mikell JL, Colbert LE, Moreno CC, Squires MH, Fisher SB, Yu DS, Kooby DA, Maithel SK, Landry JC. Cholangiocarcinoma size on magnetic resonance imaging versus pathologic specimen: Implications for radiation treatment planning. Pract Radiat Oncol 6(3):201-206, 2016. e-Pub 2016. PMID: 26979545.
- Seldon CS, LE C, Hall WA, Fisher SB, Yu DS, Landry JC. Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas. World J Gastrointest Oncol 8(4):358-65, 2016. e-Pub 2016. PMID: 27096031.
- Cheng J, Squires MH, Mikell JL, Fisher SB, Staley CA, Kooby DA, El-Rayes BF, Curran WJ, Hall WA, Colbert LE, Shelton JW, Maithel SK, Landry J, Yu DS. Radiotherapy patterns of care in gastric adenocarcinoma: a single institution experience. J Gastrointest Oncol 6(3):247-53, 2015. e-Pub 2015. PMID: 26029450.
- Colbert LE, Fisher SB, Balci S, Saka B, Chen Z, Kim S, El-Rayes BF, Adsay NV, Maithel SK, Landry JC, Curran WJ. High nuclear hypoxia-inducible factor 1 alpha expression is a predictor of distant recurrence in patients with resected pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 91(3):631-9, 2015. e-Pub 2015. PMID: 25596110.
- Hall WA, Petrova AV, Colbert LE, Hardy CW, Fisher SB, Saka B, Shelton JW, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA, Volkan Adsay N, Curran WJ, Landry JC, Maithel SK, Yu DS. Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. Oncogene 33(47):5450-6, 2014. e-Pub 2014. PMID: 24276239.
- Colbert LE, Petrova AV, Fisher SB, Pantazides BG, Madden MZ, Hardy CW, Warren MD, Pan Y, Nagaraju GP, Liu EA, Saka B, Hall WA, Shelton JW, Gandhi K, Pauly R, Kowalski J, Kooby DA, El-Rayes BF, Staley CA, Adsay NV, Curran WJ, Landry JC, Maithel SK, Yu DS. CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer. Cancer Res 74(10):2677-87, 2014. e-Pub 2014. PMID: 24626090.
- Hall WA, Colbert LE, Nickleach D, Switchenko J, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC. The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. J Gastrointest Oncol 5(2):77-85, 2014. e-Pub 2014. PMID: 24772334.
- Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC. Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. Cancer 120(4):499-506, 2014. e-Pub 2014. PMID: 24390739.
- Hall WA, Colbert L, Nickleach D, Shelton J, Marcus DM, Switchenko J, Rossi PJ, Godette K, Cooper S, Jani AB. Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate. Pract Radiat Oncol 3(4):e157-64, 2013. e-Pub 2013. PMID: 24674413.
- Colbert LE, Fisher SB, Hardy CW, Hall WA, Saka B, Shelton JW, Petrova AV, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA, Adsay NV, Curran WJ, Landry JC, Maithel SK, Yu DS. Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma. Cancer 119(17):3148-55, 2013. e-Pub 2013. PMID: 23720157.
- Hall WA, Colbert LE, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC. The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. Cancer 119(12):2350-7, 2013. e-Pub 2013. PMID: 23625519.
- Hall WA, Mikell JL, Mittal P, Colbert L, Prabhu RS, Kooby DA, Nickleach D, Hanley K, Sarmiento JM, Ali AN, Landry JC. Tumor size on abdominal MRI versus pathologic specimen in resected pancreatic adenocarcinoma: implications for radiation treatment planning. Int J Radiat Oncol Biol Phys 86(1):102-7, 2013. e-Pub 2013. PMID: 23290442.
- Kim M, Maldonado AJ, Pandey P, El Alam M, Kouzy R, Christopherson K, Minsky B, Nguyen QN, Grosshans D, Lin L, Mitchell M, Klopp A, Lee P, Bird J, Satcher R, Lewis V, Lin P, Tang C, Koong A, Moon B, Colbert L. Retreatment after single-fraction radiation therapy for bone metastases in a rapid access clinic. BMJ Supportive & Palliative Care.
Invited Articles
- Negron-Figueroa D, Colbert LE. Understanding Potential Mechanisms for a Role of the Intratumoral Microbiome in Potentiating Immunotherapy Response. Journal of Clinical Oncology.
Other Articles
- Court, K, Karpinets, T, Mitra, A, Solley, T, Dorta-Estremera, S, Sims, TT, Delgado Medrano, AY, Alam, MB, Ahmed-Kaddar, M, Lynn, EJ, Jagannatha Sastry, K, Zhang, J, Futreal, A, Nick, AM, Lu, K, Colbert, LE, Klopp, AH Erratum. PloS one 19(11):e0314643, 2024. PMID: 39576772.
Editorials
- Colbert LE, Kouzy R, Abi Jaoude J, Ludmir EB, Taniguchi CM. Cancer Research after COVID-19: Where Do We Go from Here?. Cancer Cell 37(5):637-638, 2020. PMID: 32396859.
- Kouzy R, Abi Jaoude J, Yue J, Maldonado JA, Taniguchi CM, Ludmir EB, Colbert LE. Applying to Radiation Oncology Amid a Pandemic. Adv Radiat Oncol 5(4):777-779, 2020. PMID: 32775792.
Book Chapters
- Colbert LE, Jhingran A. Immunotherapy and Radiation. In: Immunotherapy, 3rd Edition, 2022.
- Lee, A, Colbert, LE, Fuller, C. Identifying and utilizing mentors, 91-105, 2021.
- Lee A, Colbert LE, Fuller CD. Identifying and Utilizing Mentors in Career Development. In: Academic Radiation Oncology. Springer Nature, 2021.
- Eifel P, Colbert L. Radiation Therapy. In: Berek & Hacker's Gynecologic Oncology, 7th Edition, 2020.
- Colbert LE, Yuan Y, Zindler J, Fuller CD, Thomas CR. Radiotherapy Considerations and Strategic Approaches in Phase I Trials. In: Phase I Oncology Drug Development, 2020.
- Colbert LE, Das P. Hepatobiliary Cancer. In: MD Anderson Handbook of Radiation Oncology. Wolters Kluwer, 2018.
- Moningi S, Colbert LE, Das P. Pancreatic Cancer. In: MD Anderson Handbook of Radiation Oncology. Wolters Kluwer, 2018.
- Colbert LE. Post-operative Neck Management. In: Radiation Oncology: A Question-Based Review, 3rd edition. LWW, 2018.
- Colbert LE. Early Stage Breast Cancer. In: Radiation Oncology: A Question-Based Review, 3rd edition. 3 rd. LWW, 2018.
- Colbert LE. Early Stage Lung Cancer. In: Radiation Oncology: A Question-Based Review, 3rd edition. LWW, 2018.
- Colbert LE, Das P. Gastric Cancer. In: MD Anderson Handbook of Radiation Oncology. Wolters Kluwer, 2018.
- Colbert LE, Das P. Gastrointestinal Section Editor. In: MD Anderson Handbook of Radiation Oncology. Wolters Kluwer, 2018.
- Colbert LE, Minsky BM, Fuller CD. Clinical Biostatistics. In: MD Anderson Handbook of Radiation Oncology. Wolters Kluwer, 2018.
- Rosati L, Moningi S, Colbert LE, Herman JM. Novel Radiotherapy Modalities. In: Current and Emerging Therapies in Pancreatic Cancer. Springer Publishing, 2017.
- Colbert LE, Epstein A. Issues in Hospitalized Patients with Gastrointestinal Cancers. In: In Principles and Practice of Hospital Medicine. McGraw Hill, 2015.
- Colbert LE, Cassidy R, Marcus DM, Landry J. Radiotherapy for Pancreatic Cancer. In Q. Cai. In: Gastrointestinal Malignancies. World Scientific Publishing, 2015.
Selected Presentations & Talks
National Presentations
- 2025. Lactic acid bacteria in the tumor microenvironment and radiation response. Invited. AACR Town Hall Talk. Chicago, IL, US.
- 2024. Grand Rounds Presentation: Endowed Saxena Lecture. Invited. New York, NY, US.
- 2024. Jobs Panel - Academic. Invited. ARRO Annual Resident Seminar. Washington, DC, US.
- 2024. AACR RSM Webinar Series Inaugural Webinar: Dismutase Combined with SBRT: A Clinical Success Story for Pancreatic Cancer. Invited. AACR RSM Working Group, US.
- 2022. State of the Science: The Cervicovaginal Microbiome in Gynecologic Cancers - Educational Session. Invited. 65th ASTRO Annual Meeting. San Antonio, TX, US.
- 2020. ARRO Seminar 03: ARRO Mentorship and Networking Session. Invited. 63rd ASTRO Annual Meeting, US.
- 2019. Exceptional Response to Radiation Therapy for Cervical Cancers is Associated with Higher Predicted Tumor Neoantigen Burden and Selective Loss of Neoantigens. Conference. 61st Annual ASTRO Meeting. Chicago, IL, US.
- 2018. Implementation of a rapid access multidisciplinary bone metastases clinic to improve access to care at a large cancer center. Conference. ASCO Palliative and Supportive Care in Oncology Symposium. San Diego, CA, US.
- 2018. In vivo shRNA screening reveals differential radiosensitization within HPV+ and HPV-head and neck squamous cell carcinomas. Conference. 60th Annual ASTRO Meeting. San Antonio, TX, US.
- 2018. Clonal Expansion of Antigen Specific T-cells during Radiation Therapy for HPV associated Cervical Cancers is Regulated by the Vaginal Microbiome. Conference. 60th Annual ASTRO Meeting. San Antonio, TX, US.
- 2017. Rectal Microbiome Diversity Predicts Disease Response at Completion of Radiation Therapy for Squamous Cell Carcinoma of the Cervix. Conference. 59th Annual ASTRO Meeting. San Diego, CA, US.
- 2017. Chemoradiation for cervical squamous cell carcinoma induces transient decrease in T cell infiltrate followed by variable expansion in the number and diversity of T-cell repertoire. Conference. 3rd Annual Immuno-oncology Young Investigators’ Forum. Houston, TX, US.
- 2016. Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB). Conference. Texas Society for Clinical Oncology, TX, US.
- 2016. Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB). Conference. 58th Annual ASTRO Meeting. Boston, MA, US.
- 2015. Single Fraction Palliative Radiation Therapy for Painful Bony Metastases. Conference. Memorial Sloan-Kettering Cancer Center Department of Medicine Grand Rounds. Transitional Year Program: Peer-Selected Best Evidence-Based Medicine Presentation, US.
- 2014. Nuclear Hypoxia-Inducible Factor 1 Alpha is a Predictor of Distant Failure in Patients with Resected Pancreatic Adenocarcinoma. Conference. 56th Annual ASTRO Meeting. San Francisco, CA, US.
- 2014. Using Observed Structured Teaching Exercises (OSTE) to Enhance Bedside Physical Examination Teaching By Senior Students. Conference. 40th Anniversary STFM Conference on Medical Student Education. Nashville, TN, US.
- 2013. Pro-necrotic Mixed Lineage Kinase Domain-Like (MLKL) Protein Expression is a Prognostic Biomarker in Patients with Early-Stage Resected Pancreatic Adenocarcinoma. Conference. 55th Annual ASTRO Meeting. Atlanta, GA, US.
- 2013. Chromodomain-helicase-dna-binding Protein 7 (CHD7), A Novel Gemcitabine Sensitivity Gene, Is A Prognostic Biomarker In Patients With Early-stage Resected Pancreatic Adenocarcinoma. Conference. 55th Annual ASTRO Meeting. Atlanta, GA, US.
- 2013. Much of What I Really Needed to Know About Being a Good Doctor I Learned From My Intern: The Pivotal Role of the Intern in Bedside Teaching. Conference. Emory University School of Medicine Society Advisor Grand Rounds. Atlanta, GA, US.
International Presentations
- 2024. The Role of Lactic Acid Bacteria in the Tumor Microenvironment in Metabolic Rewiring and Therapeutic Response. Invited. International Conference on Tumor Microenvironment and Cellular Stress. Paphos, CY.
- 2024. The Role of the Tumor Microbiome in Cancer Prognosis and Response to Therapy. Invited. 10th International Human Microbiome Consortium (IHMC) Congress 2024. Rome, IT.
- 2023. Bugs as Drugs: Opportunities for tumor microbiome-based therapeutics in combination with radiation therapy (Presidential Symposium). Invited. 17th International Congress for Radiation Research (ICRR). Montreal, US.
Formal Peers
- 2024. The Cervicovaginal Microbiome in HPV-related Dysplasia and Cancer (Grand Rounds). Visiting. New York, NY, US.
- 2023. The Tumor Microbiome and its Role in Radiation Response (Keynote Speaker). Visiting. Duarte, CA, US.
- 2015. Single Fraction Radiation for Palliation of Painful Bone Metastases (Grand Rounds). Invited. New York, NY, US.
Grant & Contract Support
| Date: | 2025 - 2029 |
| Title: | Repurposing minocycline to reduce Adverse events and improve Morbidity in NSCLC Patients with Symptom burden |
| Funding Source: | Cancer Prevention Research Institute of Texas (CPRIT |
| Role: | Co-I |
| ID: | FP00025938 |
| Date: | 2024 - 2027 |
| Title: | Full Project 1: Antigen-specific immune responses associated with microbial signatures and cervical disease progression in Hispanics |
| Funding Source: | NIH/NCI |
| Role: | Project Leader |
| ID: | 5-U54-CA096300-21 |
| Date: | 2024 - 2026 |
| Title: | Lactic acid bacteria as the ultimate Trojan Horse for targeted radionuclide delivery |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP240520 |
| Date: | 2024 - 2031 |
| Title: | Targeting tumoral Lactobacillus iners to improve outcomes in cervical cancers |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 1R37CA285794 |
| Date: | 2024 - 2026 |
| Title: | Lactic Acid Bacteria as a novel therapeutic target across cancer types |
| Funding Source: | Andrew Sabin Family Foundation |
| Role: | PI |
| ID: | 2024-00063768-Y1 |
| Date: | 2023 - 2025 |
| Title: | The Cervicovaginal Microbiome as an Unexplored Predictor of Immune Checkpoint Inhibitor Response (Institutional Research Grant) |
| Funding Source: | MD Anderson Cancer Center |
| Role: | PI |
| Date: | 2023 - 2024 |
| Title: | HPV Moon Shot Priority Project 3 - Microbiome |
| Funding Source: | MD Anderson Cancer Center |
| Role: | Project Leader |
| Date: | 2023 - 2024 |
| Title: | HPV Moon Shot Priority Project 4 - Treat Minimal Residual Disease |
| Funding Source: | MD Anderson Cancer Center |
| Role: | Co-Program Leader |
| Date: | 2023 - 2024 |
| Title: | Targeting tumoral Lactobacillus iners to improve outcomes in cervical cancers (Bridge Funding) |
| Funding Source: | MD Anderson Cancer Center |
| Role: | PI |
| Date: | 2023 - 2025 |
| Title: | Identifying Novel Radiation Sensitizers in Cervical Cancer - Diversity Supplement |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 3R21CA277332-01S1 |
| Date: | 2023 - Present |
| Title: | VICTORY Houston: Targeting Lactobacillus iners to overcome cervical cancer treatment resistance |
| Funding Source: | American Society of Clinical Oncology (ASCO) |
| Role: | PI |
| Date: | 2023 - 2026 |
| Title: | Targeted Cancer-associated Lactobacillus iners to improve response to cancer therapy |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP230316 |
| Date: | 2022 - 2024 |
| Title: | Identifying Novel Radiation Sensitizers in Cervical Cancer, National Institutes of Health |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 1-R21-CA277332-01 |
| Date: | 2022 - 2024 |
| Title: | Immune and microbial signatures for treatment response in Hispanics with cervical cancer |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator-MDACC |
| ID: | U54-CA96300 PP |
| Date: | 2022 - 2023 |
| Title: | HPV Moon Shot Priority Project 3 - Microbiome, Transforming the HPV Tumor Microbiome from Tumor Permissive to Tumor Restrictive |
| Funding Source: | MD Anderson Cancer Center |
| Role: | Project Leader |
| Date: | 2022 - 2022 |
| Title: | Wolf in Sheep’s Clothing: How does Lactobacillus iners affect Antigen-specific Immune System Remodeling after Chemoradiation for Cervical Cancer? |
| Funding Source: | MD Anderson Cancer Center |
| Role: | PI |
| ID: | 2021-00059649-Y1 |
| Date: | 2021 - 2026 |
| Title: | Novel Functional Anatomic and Biomarker Indices of Radiation-Induced Female Sexual Toxicities in a Multi-Center Cohort |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 5-DP5-OD031876-03 |
| Date: | 2020 - 2021 |
| Title: | Look-alike Bugs: How do Bacteria Improve Antigen-specific Remodeling after Chemoradiation for HPV-related Cervical Cancer? (Institutional Research Grant) |
| Funding Source: | MD Anderson Cancer Center |
| Role: | PI |
| ID: | 2020-00057975-Y1 |
| Date: | 2020 - 2025 |
| Title: | Look-alike Bugs: How do Vaginal Bacteria Improve Antigen-specific Remodeling after Chemoradiation for HPV-related Cervical Cancer? (Startup Funding) |
| Funding Source: | MD Anderson Cancer Center |
| Role: | PI |
| Date: | 2019 - 2020 |
| Title: | Use of Radiomic Characteristics associated with Decreased T-cell Response to predict In-Field Failure after Definitive Chemoradiation for Anal Squamous Cell Carcinoma |
| Funding Source: | American Society of Clinical Oncology/ Conquer Cancer Foundation |
| Role: | PI |
| ID: | FP00006554 |
| Date: | 2017 - 2018 |
| Title: | A Prospective Study Characterizing Genomic and Immunologic Differences Driving Variable Radiation Response within HPV-related Cervical Carcinomas |
| Funding Source: | Radiological Society of North America |
| Role: | PI |
| ID: | RR1721 |
Patient Reviews
CV information above last modified July 14, 2025